본문으로 건너뛰기
← 뒤로

Real-Time Adaptive Respiratory Motion Compensation With Stent-Based Tracking.

1/5 보강
Cureus 2025 Vol.17(5) p. e84971
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
환자: pancreatic cancer who underwent SBRT planning using an implanted biliary stent as a surrogate for tumor motion tracking
I · Intervention 중재 / 시술
SBRT planning using an implanted biliary stent as a surrogate for tumor motion tracking
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
It underscores the need for robust quality assurance, improved tracking technologies, and consideration of online adaptive strategies to account for anatomical and surrogate variability. Further investigation is warranted to optimize motion management in pancreatic SBRT utilizing stents as tracking target surrogates.

Goddard LC, Rhieu BH, Tomé WA

📝 환자 설명용 한 줄

Stereotactic body radiation therapy (SBRT) offers a promising treatment option for locally advanced pancreatic cancer, but its precision is challenged by respiratory-induced tumor motion.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Goddard LC, Rhieu BH, Tomé WA (2025). Real-Time Adaptive Respiratory Motion Compensation With Stent-Based Tracking.. Cureus, 17(5), e84971. https://doi.org/10.7759/cureus.84971
MLA Goddard LC, et al.. "Real-Time Adaptive Respiratory Motion Compensation With Stent-Based Tracking.." Cureus, vol. 17, no. 5, 2025, pp. e84971.
PMID 40585701

Abstract

Stereotactic body radiation therapy (SBRT) offers a promising treatment option for locally advanced pancreatic cancer, but its precision is challenged by respiratory-induced tumor motion. The Radixact Synchrony system integrates real-time motion tracking using internal and external surrogates, potentially enabling reduced treatment margins. In this case study, we report on an 85-year-old female patient with pancreatic cancer who underwent SBRT planning using an implanted biliary stent as a surrogate for tumor motion tracking. Initial assessments, including 4DCT analysis and Synchrony simulation, indicated minimal motion discrepancy between the stent and tumor, supporting its use as a tracking target. However, at the time of treatment, a ~25° rotation of the stent and intermittent external LED signal interruptions impaired motion model accuracy, leading to repeated tracking failures and treatment abortion. The patient was subsequently treated using a free-breathing internal target volume approach. This case highlights both the potential and limitations of using biliary stents as surrogates in real-time motion-adaptive SBRT. It underscores the need for robust quality assurance, improved tracking technologies, and consideration of online adaptive strategies to account for anatomical and surrogate variability. Further investigation is warranted to optimize motion management in pancreatic SBRT utilizing stents as tracking target surrogates.